ArticleFrontiers in physiology2025
Effects of regular exercise on ischemia-modified albumin and total sulfhydryl levels in young women: a cross-sectional study.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07181044 (Effects of Regular Exercise on Ischemia-Modified Albumin and Total Sulfhydryl Levels in Young Women), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of Regular Exercise on Ischemia-Modified Albumin and Total Sulfhydryl Levels in Young Women
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Regular physical activity provides systemic health benefits, including improvements in redox homeostasis and antioxidant defense. Ischemia-modified albumin (IMA) and total sulfhydryl groups (-SH) serve as sensitive biomarkers of oxidative protein modification and thiol-dependent antioxidant capacity. However, evidence regarding their relationship in young women who participate in structured exercise remains limited. This study aimed to investigate associations between regular exercise and serum IMA and -SH concentrations in healthy young women to better understand potential exercise-related redox differences and sex-specific physiological profiles. Methods: This cross-sectional study included 30 healthy women aged 18-25 years, recruited from university campuses and local fitness facilities. Participants were assigned to an exercise group (n = 15), performing structured training ≥3 sessions per week for at least 1 year, or a sedentary control group (n = 15) with no structured exercise history. After ethical approval and informed consent, venous blood samples were drawn following overnight fasting. Serum IMA was measured using the albumin-cobalt binding assay, while -SH concentrations were determined via the Ellman method. All analyses were conducted in duplicate under standardized laboratory conditions. Independent samples t-tests and Cohen's d effect sizes with 95% confidence intervals were calculated. Results: Baseline anthropometric variables (age, height, weight) did not differ significantly between groups (p > 0.05). Serum IMA levels were significantly higher in the exercise group than in controls (0.75 ± 0.09 vs. 0.61 ± 0.08 ABSU; p < 0.001; d = 1.65). Conversely, -SH concentrations were significantly lower among exercising women (0.370 ± 0.046 vs. 0.447 ± 0.036 mmol/L; p < 0.001; d = -1.88). Both biomarkers showed very large effect sizes, reflecting robust differences in oxidative stress and antioxidant defense associated with regular physical training. Conclusion: This cross-sectional analysis indicates that regular structured exercise in young women is associated with a distinct redox profile characterized by elevated IMA and reduced -SH levels. This dual pattern may reflect altered redox homeostasis with increased oxidative protein modification and greater thiol utilization. IMA and -SH appear to be complementary biomarkers for evaluating exercise-related redox responses. Future longitudinal studies are needed to establish causal mechanisms and clinical significance. Clinical Trial Registration: Registered at ClinicalTrials.gov (NCT07181044) on 6 September 2025.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.